Jul 10, 2014 by Michael Douglass and Dave WilliamsonZogenix: Time to Buy This Battleground Stock?Controversy keeps swirling around Zogenix.
Jul 10, 2014 by Michael Douglass and Dave WilliamsonCelgene Gets Bad News, Shares Climb AnywayCelgene's Otezla failed a trial...and then shares jumped anyway.
Jul 9, 2014 by Michael Douglass and Dave WilliamsonBetter Buy: GlaxoSmithKline vs. AstraZenecaWhich is the better buy?
Jul 8, 2014 by Michael Douglass and Dave WilliamsonCan Dividend Stocks Novo Nordisk and Novartis Continue to Perform?Dividends and growth -- watch below to learn more about these stocks
Jul 7, 2014 by Michael Douglass and Dave WilliamsonUp 9%: Time to Buy BioDelivery Sciences International, Inc.?Does the stock have opportunity to capitalize on this great news?
Jul 7, 2014 by Michael Douglass and Dave WilliamsonA Bad Day for Spectrum Pharmaceuticals' Good NewsSpectrum gets a drug approved, and then the share price drops.
Jul 7, 2014 by Michael Douglass and Dave WilliamsonGrowth and Dividends: Europe's Best Pharma StockRead below to find out which stock it is.
Jul 4, 2014 by Michael Douglass and Dave WilliamsonWhat's the Best Dividend Stock in This Growing Market?Hip and knee implants are a big business -- find out the best investments below!
Jul 3, 2014 by Michael Douglass and Dave WilliamsonRegeneron's $4.7 Billion OpportunityRegeneron recently got some good news. Check out the video below for more information.
Jul 1, 2014 by Michael Douglass and Dave WilliamsonUp 20%: Time to Buy Amicus Therapeutics, Inc?Amicus shares spiked again today. What's going on with this stock?
Jul 1, 2014 by Michael Douglass and Dave WilliamsonWill a "Value-Destroying" Hospice Deal Derail Kindred?Kindred is not happy about Gentiva's rumored plans.
Jul 1, 2014 by Michael Douglass and Dave WilliamsonUp 14%: Time to Buy Salix Pharmaceuticals?Salix shares spiked today. Here's what's behind it.
Jun 29, 2014 by Michael Douglass and Dave WilliamsonDoes This Prove that Obamacare Was a Success?New data has come out -- will it finally show Obamacare as either a success or a failure?
Jun 28, 2014 by Michael Douglass and Dave Williamson2 Ways to Profit from the Accountability MovementExciting and potentially profitable ways that some businesses are investing in the future with accountable care and associated technology.
Jun 27, 2014 by Michael Douglass and Dave Williamson3 Must-Watch Opportunities for Rite AidHow Rite Aid continues to execute its turnaround -- and what the company needs to keep doing.
Jun 26, 2014 by Michael Douglass and Dave WilliamsonWhy Auxilium Pharmaceuticals Wants QLT, Inc.Small deal, but part of a larger trend.
Jun 26, 2014 by Michael Douglass and Dave WilliamsonHow America's 5 Biggest Pharma Stocks Stack upInterested in investing in top health care stocks? Let's start with the United States' five biggest pharmas.
Jun 26, 2014 by Michael Douglass and Dave WilliamsonWalgreen's Most Important Silver LiningWalgreen's huge opportunity with Alliance Boots should not be underestimated by investors.
Jun 26, 2014 by Michael Douglass and Dave Williamson3 Stocks for Biotech's Hottest TrendThese three companies are active in the orphan drug market -- watch below for more thoughts on their unique opportunities.
Jun 26, 2014 by Michael Douglass and Dave WilliamsonWhy I'm Avoiding This Biotech StockAegerion just hasn't delivered impressive results -- at least not yet.
